André Wyss
Chief Executive Officer bij IMPLENIA AG
Vermogen: 5 M $ op 29-02-2024
Profiel
André Wyss is Chief Executive Officer of Implenia AG.
Mr. Wyss is also on the board of Economiesuisse, Ina Invest AG and Ina Invest Holding Ltd.
and Member-Shareholders Board at E.
Merck KG.
Mr. Wyss previously occupied the position of President-Novartis Operations at Novartis AG President for Novartis Corp.
and President & Head-Pharma North America at Novartis Pharmaceuticals Corp.
(both are subsidiaries of Novartis AG).
Mr. Wyss received an undergraduate degree from School of Economics & Business Administration.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
IMPLENIA AG
0.55% | 31-12-2022 | 102 448 ( 0.55% ) | 4 M $ | 29-02-2024 |
INA INVEST HOLDING LTD.
0.61% | 31-12-2022 | 59 231 ( 0.61% ) | 1 M $ | 29-02-2024 |
Actieve functies van André Wyss
Bedrijven | Functie | Begin |
---|---|---|
IMPLENIA AG | Chief Executive Officer | 01-10-2018 |
INA INVEST HOLDING AG | Director/Board Member | 01-01-2020 |
Economiesuisse
Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Director/Board Member | - |
Ina Invest AG
Ina Invest AG Real Estate Investment TrustsFinance Ina Invest AG engages in the development of real estate properties. Its property portfolio includes hotels, offices, and residential homes. The company is headquartered in Zurich, Switzerland. | Director/Board Member | - |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Corporate Officer/Principal | 01-01-2024 |
Eerdere bekende functies van André Wyss
Bedrijven | Functie | Einde |
---|---|---|
NOVARTIS AG | Chief Operating Officer | 01-04-2018 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | President | 01-04-2014 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | President | 01-04-2014 |
Opleiding van André Wyss
School of Economics & Business Administration | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NOVARTIS AG | Health Technology |
IMPLENIA AG | Industrial Services |
Bedrijven in privébezit | 6 |
---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Economiesuisse
Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Health Services |
Ina Invest AG
Ina Invest AG Real Estate Investment TrustsFinance Ina Invest AG engages in the development of real estate properties. Its property portfolio includes hotels, offices, and residential homes. The company is headquartered in Zurich, Switzerland. | Finance |
Ina Invest Holding Ltd. | |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Health Technology |